Categories: News

HEXO Announces Election of Directors

GATINEAU, Quebec, March 09, 2022 (GLOBE NEWSWIRE) — HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) (“HEXO”), a leading producer of high-quality cannabis products, today announced that, at the annual general and special meeting of shareholders held on March 8, 2022, each of the seven director nominees was elected as a director of HEXO. Detailed results of the vote are set out below.

Nominee Votes For Votes Withheld Total Votes Cast Percentage of Votes For Percentage of Votes Withheld
Mark Attanasio 108,012,980 0 108,012,980 100% 0%
Vincent Chiara 108,012,980 0 108,012,980 100% 0%
Hélène F. Fortin 77,240,203 3,920,563 81,160,766 95.17% 4.83%
Rose Marie Gage 58,310,763 22,850,002 81,160,765 71.85% 28.15%
Rob Godfrey 108,012,980 0 108,012,980 100% 0%
Peter James Montour 75,782,705 5,378,060 81,160,765 93.37% 6.63%
Will Montour 77,304,011 3,856,755 81,160,766 95.25% 4.75%

All other items of business put forward at the meeting were approved, including the reappointment of PricewaterhouseCoopers LLP as HEXO’s auditor, the change of the location of HEXO’s registered office, the increase to the maximum number of directors from ten to twelve, the proposed share consolidation and the approval of the unallocated awards and certain prior awards under HEXO’s Amended and Restated Omnibus Long-Term Incentive Plan. Further details on these items of business can be found in the report of voting results and management information circular which are available under HEXO’s profile on SEDAR.

About HEXO

HEXO is an award-winning licensed producer of innovative products for the global cannabis market. HEXO serves the Canadian recreational market with a brand portfolio including HEXO, Redecan, UP Cannabis, Namaste Original Stash, 48North, Trail Mix, Bake Sale, REUP and Latitude brands, and the medical market in Canada, Israel and Malta. The Company also serves the Colorado market through its Powered by HEXO® strategy and Truss CBD USA, a joint venture with Molson-Coors. With the completion of HEXO’s recent acquisitions of Redecan and 48North, HEXO is a leading cannabis products company in Canada by recreational market share. For more information, please visit hexocorp.com.

For further information, please contact:

Investor Relations:

invest@hexo.com
www.hexocorp.com

Media Relations:

(819) 317-0526
media@hexo.com

Staff

Recent Posts

2026 Payer IT Outsourcing Outlook: Outcome-Based Managed Services, Production-Grade GenAI Governance, and Vendor-Risk Enforcement

Black Book Research Q4 flash survey shows health plans shifting from effort-based sourcing to KPI-backed…

9 hours ago

Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy

CHICAGO, IL / ACCESS Newswire / December 24, 2025 / Healthcare investors have seen this…

12 hours ago

Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

$4.1 million upfront with up to approximately $8.3 million of potential additional gross proceeds upon…

12 hours ago

PharmAla Issues Audited Year End 2025 and Unaudited Q1 Fiscal 2026 Financial Statements

TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”)…

12 hours ago

MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings

Purchases reflect strong confidence in the scientific differentiation and commercial potential of ateganosine CHICAGO, Dec.…

12 hours ago